)
Visual
earnings real time
Mink Therapeutics (INKT) investor relations material
Mink Therapeutics Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary10 Dec, 2025
Company overview and business model
Clinical-stage biopharmaceutical company focused on off-the-shelf invariant natural killer T (iNKT) cell therapies for cancer and immune-mediated diseases.
Proprietary platform enables allogeneic, ex-vivo expanded iNKT cells with adaptive T cell precision and NK cell potency, designed to avoid graft-versus-host disease.
Pipeline includes native and engineered iNKT cell therapies, with lead candidate agenT-797 in clinical trials for oncology and immune disorders.
Next-generation preclinical candidates target BCMA and FAP, with robust preclinical activity and IND-enabling studies underway.
Nearly 100 patients treated to date across cancer and immune-mediated indications.
Financial performance and metrics
As of September 30, 2025, 4,600,585 shares of common stock outstanding.
Net tangible book value as of September 30, 2025, was $(13.5) million, or $(2.94) per share.
After a $50 million offering at $12.99 per share, pro forma net tangible book value would be $34.8 million, or $4.12 per share.
Audit report notes recurring losses from operations and a net capital deficiency, raising substantial doubt about ability to continue as a going concern.
Use of proceeds and capital allocation
Net proceeds intended for working capital and general corporate purposes, including R&D, preclinical and clinical development, commercialization, acquisitions, collaborations, and capital expenditures.
Management retains broad discretion over allocation of proceeds.
Clarify ATM offering capacity given float limit.
How will going concern uncertainty impact operations?
Funding strategy for ARDS trial and MiNK-215 IND?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Mink Therapeutics earnings date
Q4 202518 Mar, 2026
Next Mink Therapeutics earnings date
Q4 202518 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Mink Therapeutics Inc. is a biotechnology company that focuses on developing immunotherapy treatments. The company specializes in creating allogeneic, off-the-shelf therapies derived from invariant natural killer T (iNKT) cells. These therapies are designed to target cancer and other immune-related diseases. Mink Therapeutics’ approach aims to harness the natural immune response, offering potential treatments that enhance the body’s ability to fight diseases. The company is headquartered in New York, United States, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage